Skip to main content
Equibles

MetLife Investment Management, LLC

Position in RXST — RxSight, Inc.

CIK 1529735 Whippany, NJ
Back to RXST Full portfolio

Position in RXST

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$105,302
-$27,476 QoQ
Shares Held
21,847
+1.4% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 151 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXST Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $231,772,552 across 68 Medical Devices names. RXST ranks #67 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 398,341 $36,145,462
2 SYK
Stryker Corp
 78,948 $24,855,988
3 MDT
Medtronic plc
 293,703 $22,976,385
4 BRKR
Bruker Corp
 374,119 $22,514,481
5 GMED
Globus Medical Inc
 275,556 $21,771,679
6 BSX
Boston Scientific Corp
 339,986 $14,510,602
7 EW
Edwards Lifesciences Corp
 131,633 $11,907,521
8 DXCM
Dexcom Inc
 103,307 $6,957,726

All Filings in RXST

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $105,302 21,847
2026-03-31 $132,778 21,555
2025-12-31 $226,728 21,759
2025-09-30 $195,613 21,759
2025-06-30 $282,867 21,759
2025-03-31 $549,414 21,759
2024-12-31 $754,778 21,954
2024-09-30 $1,014,550 20,525
2024-06-30 $1,187,454 19,735
2024-03-31 $748,838 14,518
2023-12-31 $585,365 14,518
2023-09-30 $404,907 14,518
2023-06-30 $418,118 14,518
2023-03-31 $201,994 12,110
2022-12-31 $153,433 12,110
2022-09-30 $145,320 12,110
2022-06-30 $170,508 12,110